A detailed history of Credit Suisse Ag transactions in Novo Nordisk A S stock. As of the latest transaction made, Credit Suisse Ag holds 6,000 shares of NVO stock, worth $636,780. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,000
Holding current value
$636,780
% of portfolio
0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$102.11 - $135.92 $612,660 - $815,519
6,000 New
6,000 $770,000
Q1 2023

May 10, 2023

SELL
$132.34 - $159.14 $1.2 Million - $1.44 Million
-9,032 Reduced 74.81%
3,041 $483,000
Q4 2022

Feb 13, 2023

SELL
$102.55 - $135.33 $152,799 - $201,641
-1,490 Reduced 10.99%
12,073 $1.63 Million
Q3 2022

Nov 10, 2022

BUY
$95.28 - $116.93 $632,278 - $775,947
6,636 Added 95.8%
13,563 $1.35 Million
Q2 2022

Aug 12, 2022

BUY
$103.24 - $121.81 $715,143 - $843,777
6,927 New
6,927 $772,000
Q4 2021

Feb 14, 2022

SELL
$95.88 - $117.08 $234,714 - $286,611
-2,448 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$84.42 - $106.62 $10.7 Million - $13.5 Million
-126,510 Reduced 98.1%
2,448 $235,000
Q2 2021

Aug 16, 2021

BUY
$67.66 - $84.76 $3.84 Million - $4.81 Million
56,697 Added 78.46%
128,958 $10.8 Million
Q1 2021

May 14, 2021

SELL
$67.06 - $75.82 $2.19 Million - $2.48 Million
-32,716 Reduced 31.16%
72,261 $4.87 Million
Q4 2020

Feb 12, 2021

SELL
$63.89 - $73.8 $20.5 Million - $23.7 Million
-321,360 Reduced 75.38%
104,977 $7.33 Million
Q3 2020

Nov 13, 2020

BUY
$63.69 - $70.22 $7.44 Million - $8.21 Million
116,888 Added 37.77%
426,337 $29.6 Million
Q2 2020

Aug 12, 2020

BUY
$58.54 - $67.94 $5.36 Million - $6.22 Million
91,608 Added 42.05%
309,449 $20.3 Million
Q1 2020

May 13, 2020

BUY
$49.46 - $64.78 $8.56 Million - $11.2 Million
173,071 Added 386.58%
217,841 $13.1 Million
Q4 2019

Feb 12, 2020

SELL
$49.86 - $58.26 $5.38 Million - $6.28 Million
-107,835 Reduced 70.66%
44,770 $2.59 Million
Q3 2019

Nov 12, 2019

BUY
$47.54 - $53.43 $2.26 Million - $2.54 Million
47,478 Added 45.16%
152,605 $7.89 Million
Q2 2019

Aug 14, 2019

SELL
$46.79 - $52.47 $13.6 Million - $15.2 Million
-290,244 Reduced 73.41%
105,127 $5.37 Million
Q1 2019

May 14, 2019

BUY
$46.36 - $52.63 $8.95 Million - $10.2 Million
193,141 Added 95.51%
395,371 $20.7 Million
Q4 2018

Feb 13, 2019

SELL
$41.54 - $47.25 $614,127 - $698,544
-14,784 Reduced 6.81%
202,230 $9.32 Million
Q3 2018

Nov 13, 2018

SELL
$46.76 - $51.24 $605,682 - $663,711
-12,953 Reduced 5.63%
217,014 $10.2 Million
Q2 2018

Aug 14, 2018

SELL
$44.29 - $50.42 $6.76 Million - $7.69 Million
-152,606 Reduced 39.89%
229,967 $10.6 Million
Q1 2018

May 15, 2018

BUY
$48.49 - $58.14 $11.3 Million - $13.6 Million
234,048 Added 157.58%
382,573 $18.8 Million
Q4 2017

Feb 14, 2018

BUY
$47.53 - $53.73 $7.06 Million - $7.98 Million
148,525 New
148,525 $7.97 Million
Q3 2017

Nov 14, 2017

SELL
$41.15 - $49.22 $43.7 Million - $52.2 Million
-1,061,251 Closed
0 $0
Q2 2017

Aug 14, 2017

BUY
N/A
1,061,251
1,061,251 $45.5 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $240B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Credit Suisse Ag Portfolio

Follow Credit Suisse Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.